0001250853-18-000043.txt : 20180319 0001250853-18-000043.hdr.sgml : 20180319 20180319162910 ACCESSION NUMBER: 0001250853-18-000043 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180315 FILED AS OF DATE: 20180319 DATE AS OF CHANGE: 20180319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WEISER MICHAEL CENTRAL INDEX KEY: 0001221449 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36860 FILM NUMBER: 18699104 MAIL ADDRESS: STREET 1: 130 EAST 75TH ST STREET 2: APT 6B CITY: NEW YORK STATE: NY ZIP: 10021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IOVANCE BIOTHERAPEUTICS, INC. CENTRAL INDEX KEY: 0001425205 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 753254381 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 999 SKYWAY ROAD STREET 2: SUITE 150 CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 6502607120 MAIL ADDRESS: STREET 1: 999 SKYWAY ROAD STREET 2: SUITE 150 CITY: SAN CARLOS STATE: CA ZIP: 94070 FORMER COMPANY: FORMER CONFORMED NAME: Lion Biotechnologies, Inc. DATE OF NAME CHANGE: 20131015 FORMER COMPANY: FORMER CONFORMED NAME: Genesis Biopharma, Inc DATE OF NAME CHANGE: 20100319 FORMER COMPANY: FORMER CONFORMED NAME: FREIGHT MANAGEMENT CORP DATE OF NAME CHANGE: 20080128 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2018-03-15 0 0001425205 IOVANCE BIOTHERAPEUTICS, INC. IOVA 0001221449 WEISER MICHAEL 999 SKYWAY ROAD, SUITE 150 SAN CARLOS CA 94070 1 0 0 0 Stock Option (right to buy) 16.2 2018-03-15 4 A 0 50000 0 A 2028-03-14 Common Stock 50000 50000 D These options are exercisable in four equal quarterly installments of 12,500 each following the date of grant. If the Reporting Person's service to the Issuer terminates before the expiration date, the option shares will be exercisable for two years following termination of service unless the Reporting Person is terminated for cause, in which case the options are terminated. /s/ Michael Weiser 2018-03-19